RAPGEF3 and non-small cell lung carcinoma: We observed that specific inhibition of Epac1 using the pharmacological inhibitor CE3F4 [37] not only decreased migration of NSCLC cells, but also abolished PGE2-induced nuclear accumulation of β-catenin, activation of β-catenin-dependent transcription and expression of the EMT regulator ZEB1.